Angelini Farmacêutica (Portugal)

Angelini Farmacêutica is in Algés, near Lisbon, and supplies a wide range of products for the pharmaceutical sector:  prescription drugs, over-the-counter (OTC) drugs, cosmetics, and food supplements are some of the product categories marketed on a national scale.
In Portugal, Angelini Farmacêutica is carrying forward the activities and role of L. Lepori, which Angelini acquired in 1979, and Helsinn, acquired later in 2001.

The main therapeutic areas of Angelini Farmacêutica in the ethical pharmaceuticals sector are: neuropsychiatry, gynecology, ophthalmology, treatment of inflammations. 

In the neuropsychiatric and neurological field, Angelini is on the market with an antidepressant drugs, brand names Triticum (trazodone), present on the domestic market for over 25 years. At this area Angelini has been demonstrating its constant striving towards innovation and specializacion, through the introduction of new formulations of Triticum, like Triticum AC and Triticum OD, that have the purpose to fit the most patients profiles possible.

The main brands in the field of gynecology are Unidrox, an antibiotic recommended for the treatment of infections of the inferior urinary tract, and Prevecist, a food supplement designed exclusively for the prevention of urinary infections.

In the treatment of inflammations, the most important brand is AdalgurN (Paracetamol - Tiocolquicosido), a drug for the treatment of musculoskeletal pain

Angelini own some of the leading market brands in relation to oral hygiene, including the Tantum line (an anti-inflammatory drug based on benzydamine).

In the field of disinfection, Angelini owns the Amukina brand, market leader in the broad-spectrum disinfectant category.

Triticum - Acutil CNS
Unidrox - Prevecist Gynecology
AdalgurN Pain/Inflammation
Tantum Cold and Flu
Amukina Disinfection
Anjelif - Barral Dermocosmetic

In the specific area of deep skin hydration Barral, a Portuguese brand with over 170 years of existence, continues to hold a position of prominence in Angelini portfolio where it has the first place in terms of sales.
Also at dermocosmetics field, Angelini lauched ANJELIF line, in Portugal, at 2014. This products are composed by the molecule Polglumyt, capable to activate the mechanisms of cellular renovation of epidermis, a fundamental action to retard the skin aging process.
In the supplements sector,  Angelini is present with the brands Optimus (it help to regenerate the joint cartilage), Magnésio OK and Magnésio B (food supplemet for the protection against magnesium deficiency), and two types of Selenium which possess a protective antioxidant effect preventing cellular aging and degenerative diseases.

The begining of 2016 was marked  with important news for Angelini Portugal. The acquisition of 5 new products: Venex, Lepicortinolo, Dyazide, Cervoxan e Cim. This products were from the company Decomed and are very important at the at many different therapeutic fields, mainly at the venotropic field. This contract means for Angelini Portugal an important opportunity to increase it portfolio.

The market share of Angelini Farmacêutica varies in the different markets.
In relation to the ethical products market Angelini has a market share of 1.3% (27th position in the national ranking). In OTC/Supplements Angelini has a market share of 3.8% (7th position in the national ranking). In dermocosmetic the market share is 2.14% (12th position).

Angelini Farmacêutica employs 130 people (61 sales representatives). The turnover is about 36 M€ (2015).